Mini Review Article | DOI: https://doi.org/10.31579/2834-8532/028
A Brief Review on Some Important Notes in The Genetics of Malignant Gliomas
- Behzad Saberi *
Medical Research, Esfahan, Iran
*Corresponding Author: Behzad Saberi, Medical Research, Esfahan, Iran
Citation: Behzad Saberi, (2023), A Brief Review on Some Important Notes in The Genetics of Malignant Gliomas. J, Clinical Genetic research, 2(3); Doi: 10.31579/2834-8532/028
Copyright: © 2023, Behzad Saberi, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 10 June 2023 | Accepted: 16 June 2023 | Published: 12 July 2023
Keywords: brain tumors; gliomas; malignancy; genetics; important notes
Abstract
Malignant gliomas which are also known as high-grade gliomas are among the brain tumors which are progressive in a rapid manner in their nature. Glioblastoma, anaplastic astrocytoma, anaplastic oligodendroglioma and mixed anaplastic oligoastrocytoma are among these malignant tumors.
There are some genes and relevant alterations which are involved in the development of malignant gliomas. This brief review tries to point to some important notes related to the malignant glioma’s genetics.
References
- Wood M.D, Halfpenny A.M., Moore S.R. (2019). Applications of molecular neuro-oncology-a review of diffuse glioma integrated diagnosis and emerging molecular entities. Diagn. Pathol, 14:29.
View at Publisher | View at Google Scholar - Riemenschneider M.J, Jeuken J.W, Wesseling P, Reifenberger G. (2010). Molecular diagnostics of gliomas: State of the art. Acta Neuropathol, 120:567-584.
View at Publisher | View at Google Scholar - Phillips H.S., Kharbanda S, Chen R., Forrest W.F, Soriano R.H, Wu T.D, Misra A, Nigro J.M, Colman H., Soroceanu L, et al. (2006). Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell, 9:157-173.
View at Publisher | View at Google Scholar - Nikiforova M.N, Hamilton R.L. (2011). Molecular diagnostics of gliomas. Arch. Pathol. Lab. Med, 135:558-568.
View at Publisher | View at Google Scholar - Guo C, Pirozzi C. J, Lopez G.Y. (2011). Yan H. Isocitrate dehydrogenase mutations in gliomas: Mechanisms, biomarkers and therapeutic target. Curr. Opin. Neurol, 24:648-652.
View at Publisher | View at Google Scholar - Verhaak R.G, Hoadley K.A, Purdom E, Wang V, Qi Y, Wilkerson M.D, Miller C.R, Ding L., Golub T, Mesirov J.P, et al (2010). Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.Cancer Cell, 17:98-110.
View at Publisher | View at Google Scholar - Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, (2008) 455:1061-1068.
View at Publisher | View at Google Scholar